Risk of primary sclerosing cholangitis is associated with nonsmoking behavior
KJ van Erpecum, SJ Smits, PC van de Meeberg… - Gastroenterology, 1996 - Elsevier
BACKGROUND & AIMS: Seventy percent of patients with primary sclerosing cholangitis
(PSC) have concomitant ulcerative colitis. Smoking and previous appendectomy may protect …
(PSC) have concomitant ulcerative colitis. Smoking and previous appendectomy may protect …
Increased gall bladder volume in primary sclerosing cholangitis.
PC Van de Meeberg, P Portincasa, FH Wolfhagen… - Gut, 1996 - gut.bmj.com
BACKGROUND: The diagnosis of primary sclerosing cholangitis (PSC) requires invasive
procedures such as liver biopsy and endoscopic retrograde cholangiography (ERC) …
procedures such as liver biopsy and endoscopic retrograde cholangiography (ERC) …
Combined treatment with ursodeoxycholic acid and prednisone in primary biliary cirrhosis.
FH Wolfhagen, HR Van Buuren… - The Netherlands Journal …, 1994 - europepmc.org
Objective To assess the effect of combined therapy (CT) of ursodeoxycholic acid (UDCA)
with prednisone on symptoms and biochemistry in patients with non-advanced primary …
with prednisone on symptoms and biochemistry in patients with non-advanced primary …
How the concept of biochemical response influenced the management of primary biliary cholangitis over time.
WJ Lammers, M Leeman, CI Ponsioen… - … Journal of Medicine, 2016 - europepmc.org
Background Criteria assessing biochemical response to ursodeoxycholic acid (UDCA) are
established risk stratification tools in primary biliary cholangitis (PBC). We aimed to evaluate …
established risk stratification tools in primary biliary cholangitis (PBC). We aimed to evaluate …
Interstitial nephritis attributed to treatment with piperacillin-tazobactam and with ciprofloxacin
L Mannaerts, AA Van der Wurff… - Nederlands Tijdschrift …, 2006 - europepmc.org
A 26-year-old man was treated with piperacillin-tazobactam because of suspected
cholangitis and a 77-year-old man was given ciprofloxacin because of an infected knee …
cholangitis and a 77-year-old man was given ciprofloxacin because of an infected knee …
Can ursodeoxycholic acid induce disease remission in primary biliary cirrhosis? The Dutch Multicentre PBC Study Group
FH Wolfhagen, HR van Buuren… - Journal of …, 1995 - pubmed.ncbi.nlm.nih.gov
The pathophysiology and treatment of cholestatic pruritus
FH Wolfhagen, HJ Engelkens… - Nederlands Tijdschrift …, 1998 - europepmc.org
Pruritus is a frequent, distressing and sometimes disabling symptom of liver and biliary tract
disorders. Results of treatment are sometimes disappointing and the pathophysiology is still …
disorders. Results of treatment are sometimes disappointing and the pathophysiology is still …
Metabolic encephalopathy can be a potentially life-threatening complication from valproic acid
MC Meinardi, GB van den Berg… - Nederlands Tijdschrift …, 2008 - europepmc.org
In two female patients of 62 and 81 years old, a metabolic encephalopathy was diagnosed
which was ascribed to the use of valproic acid. Both had elevated ammonia levels in arterial …
which was ascribed to the use of valproic acid. Both had elevated ammonia levels in arterial …
633 Long-Term Local Recurrence After Macroscopic Complete Endoscopic Resection of T1 Colorectal Cancer: Rationale for Follow-Up
Y Backes, J van Bergeijk, F ter Borg… - Gastrointestinal …, 2017 - giejournal.org
Background A shift is seen towards more endoscopic resections of T1 colorectal cancer
(CRC) as compared to surgical resections, making it even more important to determine the …
(CRC) as compared to surgical resections, making it even more important to determine the …
[CITATION][C] Triple Therapy with UDCA, Prednisone and Azathioprine in PBC: a 1-Year Randomized, Placebo-Controlled Study
FH Wolfhagen, VANH HJ, HR Van Buuren - J Hepatol, 1998